Healthcap.eu

Vivet’s Second Gene Therapy Product, VTX-803 for PFIC3 …

WebPARIS, France June 1st, 2020, Vivet Therapeutics announced today that both the Food and Drug Administration (FDA) and the European Commission (EC) have granted Orphan …

Actived: 3 days ago

URL: https://www.healthcap.eu/media/vivets-second-gene-therapy-product-vtx-803-for-pfic3-receives-us-and-european-orphan-drug-designation/

Vivet Therapeutics and Pfizer Inc. Announce FDA

WebPARIS, France and NEW YORK, N.Y.—November 18, 2020— Vivet Therapeutics (“Vivet”), a privately held gene therapy biotech company dedicated to developing treatments for …

Category: Health Go Health

GOLD’s evidence “A” rating affirms that endobronchial

WebREDWOOD CITY, California, November 11, 2019 – Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that the 2020 update from …

Category: Health Go Health

HealthCap portfolio company Fusion Pharmaceuticals to …

WebStockholm, 19 March 2024 – HealthCap announces the successful sale of one of its portfolio companies, Fusion Pharmaceuticals (“Fusion”), to AstraZeneca, for USD 2.4bn. This …

Category: Health Go Health

HealthCap strengthens senior team

WebMårten Steen Promoted to Co-Managing Partner Expanded team with the appointment of several new partners Stockholm, 7 October 2021: HealthCap, a leading European life …

Category: Health Go Health

Adcendo ApS Announces Extension of Series A financing …

WebCopenhagen, Denmark, April 4th, 2023 – Adcendo ApS (“Adcendo”), a biotech company focused on the development of breakthrough antibody-drug conjugates (ADCs) for the …

Category: Health Go Health

HelloBetter Raises €5 Million to Secure Road to Profitability

WebBerlin, Germany – September 21st, 2023 – HelloBetter, a digital health company specialising in evidence-based digital therapeutics, raises €5 million from HSBC Asset …

Category: Health Go Health

Precirix strengthens patent portfolio of its precision

WebBrussels, Belgium, 31 May 2022 – Precirix NV, a clinical-stage biotechnology company developing precision radiopharmaceuticals in oncology, today provides an update on its …

Category: Health Go Health

Hemab Therapeutics Presents Positive Phase 1 Results for HMB …

WebHMB-001 was well tolerated with no drug-related adverse or thromboembolic events; dose-dependent improvements in blood-clotting activity support the potential of HMB-001 as a …

Category: Health Go Health

Orexo publishes Annual Report for 2020

WebUppsala, Sweden – March 23, 2021 – Orexo’s Annual Report for the 2020 fiscal year has been published. The Annual Report can be downloaded on the company’s website, …

Category: Health Go Health

Precirix enters into collaboration with Eckert & Ziegler for the

WebBrussels, Belgium and Berlin, Germany, 12 September 2022 – Precirix NV and Eckert & Ziegler Eurotope GmbH (Eckert & Ziegler) have signed a collaboration agreement for the …

Category: Health Go Health

Cortendo plc Changes Name to Strongbridge Biopharma plc

WebDublin, Ireland and Trevose, Pa., USA – September 4, 2015 – Cortendo plc announced today that the Company has changed its name to Strongbridge Biopharma plc. …

Category: Health Go Health

Oncopeptides announces final terms for the fully guaranteed …

WebOncopeptides announces final terms for the fully guaranteed rights issue. THIS PRESS RELEASE MAY NOT BE MADE PUBLIC, PUBLISHED OR DISTRIBUTED, DIRECTLY …

Category: Health Go Health

Vicore receives Innovation Passport designation by the UK

WebStockholm, March 29, 2023 – Vicore Pharma Holding AB (publ) (“Vicore”), unlocking the potential of a new class of drugs – angiotensin II type 2-receptor agonists (ATRAGs), …

Category: Health Go Health